ATBPF - Antibe Therapeutics GAAP EPS of -C$0.11 August, 14 2023 02:10 PM Antibe Therapeutics 2023-08-14 14:10:41 ET More on Antibe Therapeutics Antibe Therapeutics teams up with Dalriada Drug Discovery to accelerate pipeline expansion Seeking Alpha’s Quant Rating on Antibe Therapeutics Earnings data for Antibe Therapeutics For further details see: Antibe Therapeutics GAAP EPS of -C$0.11